Molecular Regulation of Toll-like Receptors in Asthma and COPD
Authors:
Open Access
- 9 November 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 6, 312
Abstract
Asthma and chronic obstructive pulmonary disease (COPD) have both been historically associated with significant morbidity and financial burden. These diseases can be induced by several exogenous factors, such as pathogen-associated molecular patterns (PAMPs) (e.g., allergens and microbes). Endogenous factors, including reactive oxygen species and damage-associated molecular patterns (DAMPs) recognized by toll-like receptors (TLRs), can also result in airway inflammation. Asthma is characterized by the dominant presence of eosinophils, mast cells, and clusters of differentiation (CD)4+ T cells in the airways, while COPD typically results in the excessive formation of neutrophils, macrophages, and CD8+ T cells in the airways. In both asthma and COPD, in the respiratory tract, TLRs are the primary proteins of interest associated with the innate and adaptive immune responses; hence, multiple treatment options targeting TLRs are being explored in an effort to reduce the severity of the symptoms of these disorders. TLR-mediated pathways for both COPD and asthma have their similarities and differences with regards to cell types and the pro-inflammatory cytotoxins present in the airway. Because of the complex TLR cascade, a variety of treatments have been used to minimize airway hypersensitivity and promote bronchodilation. Although unsuccessful at completely alleviating COPD and severe asthmatic symptoms, new studies are focused on possible targets within the TLR cascade to ameliorate airway inflammation.Keywords
This publication has 115 references indexed in Scilit:
- Recognition of lipopolysaccharide pattern by TLR4 complexesExperimental & Molecular Medicine, 2013
- Airway cells from atopic asthmatic patients exposed to ozone display an enhanced innate immune gene profileJournal of Allergy and Clinical Immunology, 2012
- Oxidized phospholipid-induced inflammation is mediated by Toll-like receptor 2Free Radical Biology and Medicine, 2011
- Why does chronic inflammation persist: An unexpected role for fibroblastsImmunology Letters, 2011
- Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPDBritish Journal of Pharmacology, 2011
- TLR5 functions as an endocytic receptor to enhance flagellin‐specific adaptive immunityEuropean Journal of Immunology, 2010
- Air pollution and circulating biomarkers of oxidative stressAir Quality, Atmosphere & Health, 2010
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptorsNature Immunology, 2010
- Immunology of asthma and chronic obstructive pulmonary diseaseNature Reviews Immunology, 2008
- Asthma exacerbations {middle dot} 2: AetiologyThorax, 2006